How glucose affects retinal health and vision loss
Solute Transporters and Retinal Health
This study is looking at how glucose affects the health of the retina, especially for people with age-related macular degeneration, to see if understanding how retinal cells handle glucose can help find new ways to prevent vision loss.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11050381 on NIH RePORTER |
What this research studies
This research investigates the role of glucose in maintaining the health of the retina, particularly in relation to age-related macular degeneration and other blinding disorders. By using mouse models, the study aims to understand how glucose deprivation impacts retinal cells and whether certain cells in the retina can effectively manage glucose levels. The research will explore the mechanisms of glucose transport and its implications for photoreceptor function, which is crucial for vision. The findings could lead to new treatment strategies aimed at preventing vision loss in affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are experiencing age-related vision issues or conditions like macular degeneration.
Not a fit: Patients with retinal conditions unrelated to glucose metabolism or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that help preserve vision in patients suffering from age-related macular degeneration and other retinal diseases.
How similar studies have performed: Previous research has shown promising results in understanding retinal metabolism, but this specific approach to glucose transport in the retina is relatively novel.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Philp, Nancy Jean — Thomas Jefferson University
- Study coordinator: Philp, Nancy Jean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.